sorbitol has been researched along with Metabolic Syndrome in 6 studies
D-glucitol : The D-enantiomer of glucitol (also known as D-sorbitol).
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
Excerpt | Relevance | Reference |
---|---|---|
" In addition, sorbitol levels were estimated in the cataractous lenses of the obese rats." | 7.78 | Activation of sorbitol pathway in metabolic syndrome and increased susceptibility to cataract in Wistar-Obese rats. ( Giridharan, NV; Reddy, GB; Reddy, PY, 2012) |
"Experiments were carried out to investigate whether diuretics (hydrochlorothiazide + furosemide) impact on the effects of a sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor on glucose metabolism and blood pressure (BP) in metabolic syndrome SHR/NDmcr-cp(+/+) rats (SHRcp)." | 3.83 | Effects of diuretics on sodium-dependent glucose cotransporter 2 inhibitor-induced changes in blood pressure in obese rats suffering from the metabolic syndrome. ( Fujisawa, Y; Hitomi, H; Kittikulsuth, W; Nakano, D; Nishiyama, A; Rafiq, K; Rahman, A; Sohara, E; Sufiun, A; Uchida, S, 2016) |
" In addition, sorbitol levels were estimated in the cataractous lenses of the obese rats." | 3.78 | Activation of sorbitol pathway in metabolic syndrome and increased susceptibility to cataract in Wistar-Obese rats. ( Giridharan, NV; Reddy, GB; Reddy, PY, 2012) |
"Metabolic syndrome is often associated with disruption of circadian rhythm of systemic haemodynamics and cardiovascular disease." | 1.46 | Effect of a selective SGLT2 inhibitor, luseogliflozin, on circadian rhythm of sympathetic nervous function and locomotor activities in metabolic syndrome rats. ( Fujisawa, Y; Hitomi, H; Nakano, D; Nishiyama, A; Rahman, A, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Nakagawa, T | 1 |
Johnson, RJ | 1 |
Andres-Hernando, A | 1 |
Roncal-Jimenez, C | 1 |
Sanchez-Lozada, LG | 1 |
Tolan, DR | 1 |
Lanaspa, MA | 1 |
Rahman, A | 2 |
Kittikulsuth, W | 1 |
Fujisawa, Y | 2 |
Sufiun, A | 1 |
Rafiq, K | 1 |
Hitomi, H | 2 |
Nakano, D | 2 |
Sohara, E | 1 |
Uchida, S | 1 |
Nishiyama, A | 2 |
Gugliucci, A | 1 |
Reddy, PY | 1 |
Giridharan, NV | 1 |
Reddy, GB | 1 |
Yamada, N | 1 |
3 reviews available for sorbitol and Metabolic Syndrome
Article | Year |
---|---|
Fructose Production and Metabolism in the Kidney.
Topics: Animals; Cardiomegaly; Diabetic Nephropathies; Dietary Sugars; Energy Metabolism; Fatty Acids; Fruct | 2020 |
Formation of Fructose-Mediated Advanced Glycation End Products and Their Roles in Metabolic and Inflammatory Diseases.
Topics: Adenosine Triphosphate; Animals; Diabetes Mellitus, Type 2; Disease Models, Animal; Fructose; Glycat | 2017 |
[Molecular mechanisms of diabetic atherosclerosis].
Topics: Arteriosclerosis; Diabetes Complications; Glycation End Products, Advanced; Humans; Hyperinsulinism; | 2002 |
3 other studies available for sorbitol and Metabolic Syndrome
Article | Year |
---|---|
Effects of diuretics on sodium-dependent glucose cotransporter 2 inhibitor-induced changes in blood pressure in obese rats suffering from the metabolic syndrome.
Topics: Administration, Oral; Animals; Blood Pressure; Diuretics; Furosemide; Hydrochlorothiazide; Hypertens | 2016 |
Effect of a selective SGLT2 inhibitor, luseogliflozin, on circadian rhythm of sympathetic nervous function and locomotor activities in metabolic syndrome rats.
Topics: Animals; Circadian Rhythm; Locomotion; Male; Metabolic Syndrome; Rats; Sodium-Glucose Transporter 2 | 2017 |
Activation of sorbitol pathway in metabolic syndrome and increased susceptibility to cataract in Wistar-Obese rats.
Topics: Age Factors; Animals; Antioxidants; Cataract; Disease Models, Animal; Disease Susceptibility; Eye Pr | 2012 |